Lobbyist Public Search

Records prior to registration year 2005 are not available online. Contact the Lobbyist Division here for assistance.	Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
	Your comments are welcome: submit feedback

Disclosure reporting details

Back to search detail summary

Lobbyist disclosure reporting period: 01/01/2022 - 06/30/2022

Lobbyist name	Nicholas Doherty
Business name	Pharmaceutical Research and Manufacturers of America Corporation
Address	5 Eileen Road
City, state, zip code	Milton, MA 02186
Country	US
Agent type	Both
Phone	508-698-4994

Operating Expenses

No operating expenses were filed for this disclosure reporting period.

Activities, Bill Numbers and Titles

Client: Pharmaceutical Research and Manufacturers of America Corporation

Total amount paid by client; lobbyist is unable to report compensation at activity level: $1,050.00

House / Senate	Bill Number or Agency Name	Bill title or activity	Agent position	Amount	Direct business association
Senate Bill	2651	An Act relative to pharmaceutical access, costs and transparency	Oppose	$0.00	N/A
Senate Bill	2774	An Act investing in the future of our health	Oppose	$0.00	N/A
Executive	Massachusetts Health Policy Commission (HPC)	Monitored board meetings for issues related to healthcare and pharmaceuticals	Neutral	$0.00	N/A
Executive	Center for Health Information and Analysis (CHIA)	Discussed issues related to the Center's annual report, specifically those related to healthcare and pharmaceuticals	Neutral	$0.00	N/A
			Total amount	$0.00

Meals, Travel, and Entertainment Expenses

No meals, travel, or entertainment expenses were filed for this disclosure reporting period.

Additional Expenses

No additional expenses were filed for this disclosure reporting period.

Campaign Contributions

No campaign contributions were filed for this disclosure reporting period.